Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors. | Cancers (Basel) | 2023 | 37686617 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblast Heterogeneity and Its Influence on the Extracellular Matrix and the Tumor Microenvironment. | Int J Mol Sci | 2023 | 37686288 | PubTator, text mining | PubMed |
| Perspectives of circular RNAs in diabetic complications from biological markers to potential therapeutic targets (Review). | Mol Med Rep | 2023 | 37681455 | PubTator, text mining | PubMed |
| The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis. | JCI Insight | 2023 | 37669110 | PubTator, text mining | PubMed |
| Pulmonary inflammation and fibroblast immunoregulation: from bench to bedside. | J Clin Invest | 2023 | 37655660 | PubTator, text mining | PubMed |
| Systems biology approach discovers comorbidity interaction of Parkinson's disease with psychiatric disorders utilizing brain transcriptome. | Front Mol Neurosci | 2023 | 37654790 | PubTator, text mining | PubMed |
| Natural killer cells in tumor immunotherapy. | Cancer Biol Med | 2023 | 37646229 | PubTator, text mining | PubMed |
| A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. | Nat Cancer | 2023 | 37640930 | PubTator, text mining | PubMed |
| Analysis of local extracellular matrix identifies different aetiologies behind bicuspid and tricuspid aortic valve degeneration and suggests therapies. | Cell Mol Life Sci | 2023 | 37632572 | PubTator, text mining | PubMed |
| Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies. | Int J Mol Sci | 2023 | 37628834 | PubTator, text mining | PubMed |
| Precision medicine advances in idiopathic pulmonary fibrosis. | EBioMedicine | 2023 | 37625268 | PubTator, text mining | PubMed |
| Stromal inflammation, fibrosis and cancer: An old intuition with promising potential. | World J Clin Oncol | 2023 | 37583950 | PubTator, text mining | PubMed |
| Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis. | Front Immunol | 2023 | 37583701 | PubTator, text mining | PubMed |
| Fibroblast activation in response to TGFβ1 is modulated by co-culture with endothelial cells in a vascular organ-on-chip platform. | Front Mol Biosci | 2023 | 37577751 | PubTator, text mining | PubMed |
| A fibroblast-dependent TGFβ1/sFRP2 noncanonical Wnt signaling axis underlies epithelial metaplasia in idiopathic pulmonary fibrosis. | bioRxiv | 2023 | 37577522 | PubTator, text mining | PubMed |
| EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs. | Int J Mol Sci | 2023 | 37569677 | PubTator, text mining | PubMed |
| Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer. | Int J Mol Sci | 2023 | 37569299 | PubTator, text mining | PubMed |
| The application and progress of stem cells in auricular cartilage regeneration: a systematic review. | Front Cell Dev Biol | 2023 | 37564374 | PubTator, text mining | PubMed |
| Characterization of human stem cell-derived hepatic stellate cells and liver sinusoidal endothelial cells during extended in vitro culture. | Front Bioeng Biotechnol | 2023 | 37560536 | PubTator, text mining | PubMed |
| The effect of chronic lithium treatment on hippocampal progenitor cells: Transcriptomic analysis and systems pharmacology. | Brain Behav | 2023 | 37553827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=16